Monosomy 9p syndrome

Monosomy 9p syndrome (also known as 9p deletion syndrome or partial deletion of the short arm of chromosome 9) is a rare chromosomal disorder caused by a partial deletion of the short arm of chromosome 9. The critical region most commonly implicated involves band 9p22-p24, though the size and exact location of the deletion can vary among affected individuals, contributing to a spectrum of clinical severity. The syndrome affects multiple body systems. Key clinical features include intellectual disability of variable degree, craniofacial dysmorphism (trigonocephaly or metopic ridging, midface hypoplasia, flat nasal bridge, long philtrum, upslanting palpebral fissures, and anteverted nares), muscular hypotonia, and genital anomalies. Individuals with XY karyotype may present with disorders of sex development, including ambiguous genitalia or complete sex reversal (46,XY females), due to the involvement of the DMRT1 gene located at 9p24.3, which plays a critical role in gonadal development. Congenital heart defects, inguinal hernias, and structural brain anomalies may also occur. There is no cure for monosomy 9p syndrome. Management is supportive and multidisciplinary, involving early intervention programs, speech and physical therapy, surgical correction of congenital anomalies (such as cardiac defects or craniosynostosis), and endocrine management for individuals with disorders of sex development. Regular developmental assessments and monitoring of associated complications are essential. Genetic counseling is recommended for affected families to assess recurrence risk, particularly when the deletion arises from a balanced parental translocation.

Common questions about Monosomy 9p syndrome